A draft Supreme Court opinion released last week strongly suggests that a majority of the court is ready to overturn Roe v. Wade, the nearly 50-year-old precedent recognizing the constitutional right to abortion. Consequently, expanding access to safe abortion in whatever ways possible is more critical than ever—and a central way of doing so is to make medication abortion more easily accessible. A medication abortion involves two different medications approved by the U.S. Food and Drug Administration (FDA)—mifepristone and then misoprostol, taken orally, 24 hours to 48 hours apart from one another. The FDA currently approves use of medication abortion for up to 10 weeks after pregnancy.